Clinical Evaluation of DRX Plus 3543 and DRX Plus 3543C Digital Detectors
Completed · Not applicable
Conditions studied: Healthy
In brief
The purpose of this clinical study is to evaluate the imaging performance of the DRX Plus 3543 and DRX Plus 3543C Detectors (flat panel digital imaging devices) as compared to the currently marketed Carestream DRX-1 Detector. The results of this study will be included in a Traditional 510(k) FDA Submission to obtain clearance to market the new detectors in the US. The study was designed in accordance with the FDA Guidance titled "Guidance for the Submission of 510(k)'s for Solid State X-ray Imaging Devices", issued on August 6, 1999.
Key facts
- Study ID
- NCT02337959
- Run by
- Carestream Health, Inc.
- People needed
- 27
- Starts
- 2015-01-01
- Expected to finish
- 2015-03-01
- Last updated by the study team
- 2016-04-18
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- X-ray images of nearly identical positioning and exposure
- No visible image artifacts
- Subject 21years or older
- Subject has provided informed consent
- Subject is in good general health
- Subject is able to stand for two (2) x-rays
You may not qualify if…
- Images that are not clinically acceptable for clinical radiographic reading as determined by the Principal Investigator.
- Subject is pregnant or suspicious of being pregnant
- Not able or willing to provide Informed Consent, or consent is withdrawn
- Not able to collect all required case information
- Subject has a history of high radiation exposure:
- Has undergone radiation therapy
- Has had two (2) or more CT scans within the past year
Where it is running
- University of Rochester — Rochester, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.